In News:

The United Nations Environment Programme (UNEP) in its 2026 report “Safe Disposal of Unused Medicines” highlights the growing environmental and public health crisis posed by pharmaceutical waste. With rising drug consumption globally, improper disposal practices are contributing to ecological degradation and antimicrobial resistance (AMR), necessitating a comprehensive, multisectoral response.

Key Features of the UNEP Report

• The report adopts a One Health approach, recognizing the interconnectedness of human, animal, and environmental health. It proposes an integrated framework that combines waste prevention, safe disposal mechanisms, legal regulations, and public awareness across sectors such as healthcare, agriculture, and households.
• A major emphasis is placed on waste prevention as the most effective strategy, alongside the development of medicine take-back systems and strengthening governance structures.

Major Findings

1. Environmental and Health Risks

Improper disposal of medicines—through flushing, dumping, or burning—introduces pharmaceutical residues into ecosystems. This leads to:

• Antimicrobial Resistance (AMR): Identified as a major driver, with AMR directly causing 1.27 million deaths globally (2019)
• Endocrine disruption and toxicity affecting aquatic life and biodiversity
• Persistent contamination due to the inability of conventional wastewater treatment plants to remove pharmaceutical compounds completely

2. Scale of the Problem

• Up to 50% of household medicines become waste globally
• Unused medicines constitute about 3% of hazardous healthcare waste
• The unused medicine management market is projected to reach US$2.54 billion by 2032, reflecting rising healthcare consumption

3. Inefficiencies and Opportunities

• Prevention potential: Countries like the Netherlands show that 40% of medicine waste can be avoided
• Redistribution scope: Nearly 19% of unused medicines could be safely reused under strict quality conditions
• Over-preion, bulk packaging, and lack of awareness contribute significantly to wastage

Methods of Safe Disposal

The report outlines scientifically approved disposal methods:

• High-temperature incineration (800–1200°C): Most effective for hazardous pharmaceutical waste
• Waste immobilization: Encapsulation or inertization to prevent chemical leakage
• Engineered landfills: Secure containment systems for residual waste
• Co-processing: Use of cement kilns or industrial furnaces to destroy pharmaceutical compounds

Key Challenges

1. Lack of Awareness: A significant proportion of people are unaware of proper disposal methods. For instance, studies show over 50% of respondents in some countries lack knowledge of associated risks.

2. Infrastructure Gaps

• Rural and remote areas lack incineration and waste treatment facilities
• Limited access to organized collection systems hinders safe disposal

3. Weak Regulatory Frameworks

• Many countries lack mandatory take-back policies
• Fragmented governance leads to inconsistent implementation (e.g., reliance on voluntary systems in some developed countries)

4. Financial Constraints: Advanced treatment technologies such as advanced oxidation processes are effective but expensive, especially for developing nations.

5. Emergency and Humanitarian Risks: During crises, excess or mismatched drug donations lead to accumulation of expired medicines, increasing disposal burdens.

UNEP Recommendations

1. Prioritising Waste Prevention

• Improve WASH (Water, Sanitation, and Hygiene), vaccination, and disease prevention
• Promote rational drug use and better diagnostics

2. Establishing Take-Back Systems

• Implement national-level collection programmes for households, pharmacies, and farms
• Ensure safe channels for returning unused medicines

3. Strengthening Legal Frameworks

• Introduce Extended Producer Responsibility (EPR) to make pharmaceutical companies responsible for post-consumer waste
• Develop binding regulations for safe disposal

4. Promoting Rational Use of Medicines

• Encourage unit-dose packaging
• Reduce over-preion and patient stockpiling

5. Enhancing Monitoring and Awareness

• Use digital tracking systems to monitor medicine usage and disposal
• Conduct public awareness campaigns to change consumer behavior